companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • Screening
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For you
  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

Cell to Cure ApS

CVR: 39401975

Declining 42% p.a.Small companyEstablished (8 yrs)Loss-making

Secondary names: Cell2Cure ApS

Previous names: Cell2Cure ApS

Active
Own this company?

About Cell to Cure ApS

Cell to Cure ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cell2Cure ApS. The management consists of Martin Roland Jensen, Annette Ekblond and Jens Kastrup. The company's owners include MEDIC ADVICE ApS, Endeavour Cells ApS and Ekblond.ApS. In 2025, the company reported a gross profit of DKK -3,076,475 and a net result of DKK -9,792,604. Equity amounted to DKK -1,179,103.

Your company? Claim the profile and show your logo, website and social channels — for free.

Claim this profile

Overview

Company type
APS
Anpartsselskab
Address
c/o Jens Kastrup, Kajerødgård 9, 3460 Birkerød
RUDERSDAL
3460 Birkerød
Find nearby companies
Founded
7.3.2018

Details

Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Code: 721000
Capital
120.288 kr.

Contact

Advertising protected

Purpose

Selskabets formål er at drive virksomhed med handel, rådgivning og assistance inden for farmaceutisk og bioteknologisk industri og beslægtede brancher, samt anden dermed beslægtet virksomhed.

Location

Google Maps|Apple Maps|OpenStreetMap

Financials

YearGross ProfitProfit/LossTotal AssetsEquityEmployeesReport
2025-3.1 mio.-9.8 mio.9.6 mio.-1.2 mio.12
2023100 t.-1.5 mio.1.9 mio.-1.9 mio.5
2022389 t.-402 t.1.5 mio.-366 t.5
2021295 t.218 t.1 mio.695 t.0
2020523 t.405 t.839 t.462 t.0

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Industry Benchmarks

View industry report

Compared to 1.054 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

Employees
Company12
Industry median4
3.0x
Equity ratio
Company-12.3%
Industry median73.0%
100% below

Comparison is based on industry median values

Ownership

Owners
MEDIC ADVICE ApS
CVR: 29193320
5-9,99%
Endeavour Cells ApS
CVR: 37244031
50-66,65%
Ekblond.ApS
CVR: 39389266
10-14,99%
Cell to Cure ApS
CVR: 39401975

Management

Directors

Jens Kastrup(ADM. DIR.)
Annette Ekblond(DIREKTØR)
Mandana Haack-Sørensen(DIREKTØR)
Martin Roland Jensen(DIREKTØR)

Board

Anders Østergaard(FORMAND)
Annette Ekblond(BESTYRELSESMEDLEM)
Jens Kastrup(BESTYRELSESMEDLEM)
Mandana Haack-Sørensen(BESTYRELSESMEDLEM)
Martin Roland Jensen(BESTYRELSESMEDLEM)

PEP screening

Screen owners and management against the Danish FSA's official PEP lists

Founders

Ekblond.ApS
JKastrup.ApS
LMN.ApS

Production units (4)

Cell to Cure ApS
P-no: 1023424734
Kajerødgård 9, 3460, Birkerød
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Cell to Cure ApS
P-no: 1029259441
Transformervej 8, 2860, Søborg
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Cell to Cure ApS
P-no: 1032092868
Rønnegade 2 4., 2100, København Ø
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Cell to Cure Clinic
P-no: 1032051886
Dronningensgade 97C 1., 7000, Fredericia
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

Is this your company?

Free

Claim this page to add your logo and social links. Free to get started.

  • Verified badge on your profile
  • Upload your logo
  • Links to your website and social channels

History

27 events
2026
Cell to Cure ApS: The 2025 annual report is outMay 22, 2026

Cell to Cure ApS has published its annual report for 2025. Gross profit came to DKK -3,076,475, and the net result was DKK -9,792,604.

2025
Cell2Cure ApS changes name to Cell to Cure ApSJul 7, 2025

On July 7, 2025, the company changed its name from Cell2Cure ApS to Cell to Cure ApS.

Cell to Cure ApS publishes interim reportMay 19, 2025

Cell to Cure ApS has published its interim report for the period September 1, 2023 – December 31, 2024.

2024
Jesper Kihl leaves the board of Cell to Cure ApSJan 12, 2024

As of January 12, 2024, Jesper Kihl has left the board of directors of Cell to Cure ApS.

Anders Østergaard joins the board of Cell to Cure ApSJan 5, 2024

As of January 5, 2024, Anders Østergaard has joined the board of directors of Cell to Cure ApS.

Martin Roland Jensen joins the board of Cell to Cure ApSJan 5, 2024

As of January 5, 2024, Martin Roland Jensen has joined the board of directors of Cell to Cure ApS.

Martin Roland Jensen leaves the board of Cell to Cure ApSJan 4, 2024

As of January 4, 2024, Martin Roland Jensen has left the board of directors of Cell to Cure ApS.

MEDIC ADVICE ApS registered as owner of Cell to Cure ApSJan 3, 2024

As of January 3, 2024, MEDIC ADVICE ApS is registered as an owner of Cell to Cure ApS with an ownership share of 5%.

Endeavour Cells ApS registered as owner of Cell to Cure ApSJan 3, 2024

As of January 3, 2024, Endeavour Cells ApS is registered as an owner of Cell to Cure ApS with an ownership share of 50%.

Ekblond.ApS registered as owner of Cell to Cure ApSJan 3, 2024

As of January 3, 2024, Ekblond.ApS is registered as an owner of Cell to Cure ApS with an ownership share of 10%.

JKastrup.ApS registered as owner of Cell to Cure ApSJan 3, 2024

As of January 3, 2024, JKastrup.ApS is registered as an owner of Cell to Cure ApS with an ownership share of 10%.

LMN.ApS registered as owner of Cell to Cure ApSJan 3, 2024

As of January 3, 2024, LMN.ApS is registered as an owner of Cell to Cure ApS with an ownership share of 10%.

2023
Cell to Cure ApS: The 2023 annual report is outNov 17, 2023

Cell to Cure ApS has published its annual report for 2023. Gross profit came to DKK 100,337, and the net result was DKK -1,533,822.

Cell to Cure ApS: The 2022 annual report is outMar 1, 2023

Cell to Cure ApS has published its annual report for 2022. Gross profit came to DKK 389,024, and the net result was DKK -401,864.

2022
Martin Roland Jensen joins the board of Cell to Cure ApSDec 13, 2022

As of December 13, 2022, Martin Roland Jensen has joined the board of directors of Cell to Cure ApS.

Annette Ekblond joins the board of Cell to Cure ApSDec 13, 2022

As of December 13, 2022, Annette Ekblond has joined the board of directors of Cell to Cure ApS.

Jens Kastrup joins the board of Cell to Cure ApSDec 13, 2022

As of December 13, 2022, Jens Kastrup has joined the board of directors of Cell to Cure ApS.

Mandana Haack-Sørensen joins the board of Cell to Cure ApSDec 13, 2022

As of December 13, 2022, Mandana Haack-Sørensen has joined the board of directors of Cell to Cure ApS.

Jesper Kihl joins the board of Cell to Cure ApSDec 13, 2022

As of December 13, 2022, Jesper Kihl has joined the board of directors of Cell to Cure ApS.

Martin Roland Jensen joins Cell to Cure ApS as directorMar 11, 2022

As of March 11, 2022, Martin Roland Jensen is registered as director of Cell to Cure ApS.

2021
Cell to Cure ApS: The 2021 annual report is outNov 26, 2021

Cell to Cure ApS has published its annual report for 2021. Gross profit came to DKK 294,954, and the net result was DKK 217,939.

2020
Cell to Cure ApS: The 2020 annual report is outNov 6, 2020

Cell to Cure ApS has published its annual report for 2020. Gross profit came to DKK 523,178, and the net result was DKK 405,000.

2019
Cell to Cure ApS publishes interim reportNov 15, 2019

Cell to Cure ApS has published its interim report for the period March 7, 2018 – August 31, 2019.

2018
Annette Ekblond joins Cell to Cure ApS as directorMar 7, 2018

As of March 7, 2018, Annette Ekblond is registered as director of Cell to Cure ApS.

Jens Kastrup joins Cell to Cure ApS as adm. dir.Mar 7, 2018

As of March 7, 2018, Jens Kastrup is registered as adm. dir. of Cell to Cure ApS.

Mandana Haack-Sørensen joins Cell to Cure ApS as directorMar 7, 2018

As of March 7, 2018, Mandana Haack-Sørensen is registered as director of Cell to Cure ApS.

Cell to Cure ApS is foundedMar 7, 2018

Cell to Cure ApS was founded on March 7, 2018.

Similar companies

Companies in the same industry and area

JKastrup.ApS

CVR 39389398

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik434 mRUDERSDAL

Jkastrup2

CVR 43067745

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik434 mRUDERSDAL

Biolytics Pharma

CVR 34040699

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik632 mRUDERSDAL0 employees

JSK Consulting

CVR 46418077

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik1.0 kmRUDERSDAL

Holger Rootzén

CVR 42067326

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik1.0 kmRUDERSDAL